This survey examines:
- your experience of regulatory safety communications
- your views on their effectiveness
- which information channels you prefer
It is part of an EU-wide project called SCOPE (Strengthening Collaboration for Operating Pharmacovigilance in Europe). This project aims to help medicines regulatory agencies including MHRA fulfil the requirements of pharmacovigilance legislation introduced in 2012. Your answers will be used to optimise regulatory safety communications.
This survey is anonymous and will take roughly 15 minutes to complete. We will not use your name if we publish the survey results. If you would like to receive a copy of the publication please fill in your email address on the final page.
We greatly appreciate your time and opinions.
Article citation: Drug Safety Update volume 8 issue 11 June 2015: 4.